Evidence map›Paper›PMID 42531048›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

A Generative Neuro-Symbolic AI for Protein Sequence Design.

Marianne Defresne, Delphine Dessaux, Samuel Buchet, Lucie Barthe, Liza Ammar-Khodja, Bessam Azizi, Valentin Durante, Gianluca Cioci, Simon de Givry, Alain Roussel and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marianne DefresneTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.
Delphine DessauxTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.
Samuel BuchetMIAT, Université de Toulouse, ANITI, INRAE, Toulouse, France.
Lucie BartheTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.
Liza Ammar-KhodjaLISM, CNRS, Université d'Aix-Marseille, Marseille, France.
Bessam AziziTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.
Valentin DuranteMIAT, Université de Toulouse, ANITI, INRAE, Toulouse, France.
Gianluca CiociTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.
Simon de GivryMIAT, Université de Toulouse, ANITI, INRAE, Toulouse, France.
Alain RousselLISM, CNRS, Université d'Aix-Marseille, Marseille, France.
Luis F Garcia-AllesTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.
Thomas SchiexMIAT, Université de Toulouse, ANITI, INRAE, Toulouse, France.ORCID https://orcid.org/0000-0001-6049-3415
Sophie BarbeTBI, Université de Toulouse, CNRS, INRAE, INSA, ANITI, Toulouse, France.ORCID https://orcid.org/0000-0003-2581-5022

Funding

ANITI AI cluster ANR-23-IACL-0002CALMIP 2022-P21025CALMIP 2022-P22014CALMIP 2024-P23015EUR BioEco ANR-18-EURE-0021French National Research Agency (ANR) ANR-19-CE09-0032French National Research Agency (ANR) ANR-19-PIA3-0004French National Research Agency (ANR) ANR-22-CE45-0025Jean-Zay GENCI-IDRIS 2022-AD011013779
6 · The paper itself

Abstract

Deep learning has revolutionized computational protein design, enabling the generation of sequences that fold onto target backbones with unprecedented accuracy. However, state-of-the-art inverse folding tools largely rely on auto-regressive sampling. While powerful, this paradigm is increasingly recognized for its inability to "think ahead", a crucial capacity to reliably create the complex, long-range inter-residue dependencies essential for most biological functions. To overcome these fundamental limitations, we introduced EffieDes, a generative neuro-symbolic AI framework that synergizes the predictive capabilities of deep learning with the logical precision of automated reasoning. EffieDes leverages deep learning to encode the target backbone's fitness landscape into Effie-a fully decomposable probabilistic graphical model (Potts model). This landscape can then be rigorously explored by an automated reasoning prover to identify sequences that simultaneously satisfy complex design constraints and optimize backbone fitness. We validated this neuro-symbolic approach through the design of orthogonal sequence pairs that adopt identical folds but exhibit selective self-assembly, as well as the design of a de novo selective nanobody with nanomolar affinity for an immune-evasive SARS-CoV-2 variant. EffieDes provides a robust architecture for precisely dissecting learned fitness landscapes, offering a new path toward proteins with highly optimized performances and sophisticated functional objectives.

Indexed as

bacterial microcompartmentsgenerative AIinverse foldingnanobodiesneuro‐symbolic AIprotein designprotein engineering

Identifiers

PMID42531048
PMCPMC13422582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.